Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

gp130 activation is regulated by D2–D3 interdomain connectivity

View through CrossRef
Activation of the IL-6 (interleukin 6) receptor subunit gp130 (glycoprotein 130) has been linked to the formation of complexes with IL-6 and the IL-6 receptor, as well as to gp130 dimerization. However, it has been shown that gp130 is present as a pre-formed dimer, indicating that its activation is not solely dependent on dimerization. Therefore the detailed mechanism of gp130 activation still remains to be deciphered. Recently, deletion mutations of gp130 have been found in inflammatory hepatocellular adenoma. The mutations clustered around one IL-6-binding epitope of gp130 and resulted in a ligand-independent constitutively active gp130. We therefore hypothesized that conformational changes of this particular IL-6-binding epitope precedes gp130 activation. Using a rational structure-based approach we identified for the first time amino acids critical for gp130 activation. We can show that gp130 D2–D3 interdomain connectivity by hydrophobic residues stabilizes inactive gp130 conformation. Conformational destabilization of the EF loop present in domain D2 and disruption of D2–D3 hydrophobic interactions resulted in ligand-independent gp130 activation. Furthermore we show that the N-terminal amino acid residues of domain D1 participate in the activation of the gp130 deletion mutants. Taken together we present novel insights into the molecular basis of the activation of a cytokine receptor signalling subunit.
Title: gp130 activation is regulated by D2–D3 interdomain connectivity
Description:
Activation of the IL-6 (interleukin 6) receptor subunit gp130 (glycoprotein 130) has been linked to the formation of complexes with IL-6 and the IL-6 receptor, as well as to gp130 dimerization.
However, it has been shown that gp130 is present as a pre-formed dimer, indicating that its activation is not solely dependent on dimerization.
Therefore the detailed mechanism of gp130 activation still remains to be deciphered.
Recently, deletion mutations of gp130 have been found in inflammatory hepatocellular adenoma.
The mutations clustered around one IL-6-binding epitope of gp130 and resulted in a ligand-independent constitutively active gp130.
We therefore hypothesized that conformational changes of this particular IL-6-binding epitope precedes gp130 activation.
Using a rational structure-based approach we identified for the first time amino acids critical for gp130 activation.
We can show that gp130 D2–D3 interdomain connectivity by hydrophobic residues stabilizes inactive gp130 conformation.
Conformational destabilization of the EF loop present in domain D2 and disruption of D2–D3 hydrophobic interactions resulted in ligand-independent gp130 activation.
Furthermore we show that the N-terminal amino acid residues of domain D1 participate in the activation of the gp130 deletion mutants.
Taken together we present novel insights into the molecular basis of the activation of a cytokine receptor signalling subunit.

Related Results

Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model
Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model
OBJECTIVE: gp130 cytokines are placed as auto-paracrine regulators of pituitary function, since they, as well as their receptors, have been shown to be expressed in and to act in n...
Abstract 4598: GP130 as a novel therapeutic target in il-6-dependent cancers
Abstract 4598: GP130 as a novel therapeutic target in il-6-dependent cancers
Abstract The IL-6/GP130 signaling pathway is critical for the survival and progression of cancer cells of multiple cancer types. We report here the new discovery of ...
Data from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
Data from Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target
<div>Abstract<p>Predicting bladder cancer progression is important in selecting the optimal treatment for bladder cancer. Because current diagnostic factors regarding p...
A74-01 Gp130 Promotes Airway Remodeling After Injury by Activating Pgk1
A74-01 Gp130 Promotes Airway Remodeling After Injury by Activating Pgk1
Abstract Rationale Tracheal fibrosis, which leads to airway stenosis, is characterized by fibroblast activation and extra...
Oncogenic deletion mutants of gp130 signal from intracellular compartments
Oncogenic deletion mutants of gp130 signal from intracellular compartments
Interleukin 6 and hence activation of the IL-6 receptor signalling subunit gp130 have been linked to inflammation and tumour formation. Recently, deletion mutations in gp130 have b...
Intracellular Proteins and Mechanisms Involved in the Control of gp130/JAK/STAT Cytokine Signaling
Intracellular Proteins and Mechanisms Involved in the Control of gp130/JAK/STAT Cytokine Signaling
AbstractCytokines regulate many cellular responses such as proliferation, differentiation and survival and play regulatory roles in numerous organ systems. The cytokines of the IL‐...
Abstract 1427: IL6 trans-signaling robustly promotes the expansion and antitumor activity of CAR T cells
Abstract 1427: IL6 trans-signaling robustly promotes the expansion and antitumor activity of CAR T cells
Abstract Chimeric antigen receptor T (CAR T) cell immunotherapy targeting CD19 positive B cells malignancies induces promising clinical remissions. However, the trea...

Back to Top